EMA
approval
· 2024-06-20
EMA Authorised: Atosiban SUN (atosiban (as acetate)) — Sun Pharmaceutical Industries Europe B.V.
Summary
The EMA authorised Atosiban SUN (atosiban) for use in managing preterm labor during pregnancy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Obstetric Labor, Premature. MAH: Sun Pharmaceutical Industries Europe B.V.. Decision date: 21/03/2024